{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:37:05Z","timestamp":1791286625438,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.beem.2012.02.001","type":"journal-article","created":{"date-parts":[[2012,5,23]],"date-time":"2012-05-23T00:31:05Z","timestamp":1337733065000},"page":"497-505","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Subclinical Cushing\u2019s syndrome"],"prefix":"10.1016","volume":"26","author":[{"given":"Monica","family":"De Leo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Cozzolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Colao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Pivonello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.beem.2012.02.001_bib1","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1056\/NEJMcp065470","article-title":"Clinical practice. The incidentally discovered adrenal mass","volume":"356","author":"Young","year":"2007","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.beem.2012.02.001_bib2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1530\/eje.0.1490273","article-title":"Prevalence and natural history of adrenal incidentalomas","volume":"149","author":"Barzon","year":"2003","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.beem.2012.02.001_bib3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1365-2265.1998.00357.x","article-title":"Subclinical Cushing\u2019s syndrome in adrenal incidentaloma","volume":"48","author":"Terzolo","year":"1998","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1016\/j.beem.2012.02.001_bib4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1530\/eje.0.1460061","article-title":"Development of overt Cushing\u2019s syndrome in patients with adrenal incidentaloma","volume":"146","author":"Barzon","year":"2002","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.beem.2012.02.001_bib5","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.1210\/jc.2003-030871","article-title":"Diagnosis and complications of Cushing\u2019s syndrome: a consensus statement","volume":"88","author":"Arnaldi","year":"2003","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2012.02.001_bib6","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1530\/EJE-10-0602","article-title":"Accuracy of several parameters of hypothalamic-pituitary-adrenal axis activity in predicting before surgery the metabolic effects of the removal of an adrenal incidentaloma","volume":"163","author":"Eller-Vainicher","year":"2010","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.beem.2012.02.001_bib7","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1210\/jc.2009-0468","article-title":"Bone mineral density, prevalence of vertebral fractures and bone quality in patients with adrenal incidentalomas with and without subclinical hypercortisolism: an Italian multicenter study","volume":"94","author":"Chiodini","year":"2009","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2012.02.001_bib8","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1210\/jcem.84.7.5856","article-title":"Altered bone mass and turnover in female patients with adrenal incidentaloma: the effect of subclinical hypercortisolism","volume":"84","author":"Torlontano","year":"1999","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2012.02.001_bib9","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1530\/eje.0.1440401","article-title":"Biochemical screening for subclinical cortisol-secreting adenomas amongst adrenal incidentaloma","volume":"144","author":"Valli","year":"2001","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.beem.2012.02.001_bib10","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.1210\/jcem.86.11.8022","article-title":"Bone loss rate in adrenal incidentalomas: a longitudinal study","volume":"86","author":"Chiodini","year":"2001","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2012.02.001_bib11","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.1210\/jc.2002-020399","article-title":"Bone involvement in eugonadal male patients with adrenal incidentaloma and subclinical hypercortisolism","volume":"87","author":"Chiodini","year":"2002","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2012.02.001_bib12","first-page":"826","article-title":"Preclinical Cushing\u2019s syndrome in adrenal incidentalomas: comparison with adrenal Cushing\u2019s syndrome","volume":"75","author":"Reincke","year":"1992","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2012.02.001_bib13","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1210\/jcem.79.6.7989452","article-title":"Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas)","volume":"79","author":"Osella","year":"1994","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2012.02.001_bib14","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1530\/eje.1.01959","article-title":"Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenoma","volume":"153","author":"Terzolo","year":"2005","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.beem.2012.02.001_bib15","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1210\/jc.2003-031413","article-title":"Spinal volumetric bone mineral density and vertebral fractures in female patients with adrenal incidentalomas: the effect of subclinical hypercortisolism and gonadal status","volume":"89","author":"Chiodini","year":"2004","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2012.02.001_bib16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1530\/EJE-08-0485","article-title":"The limited role of midnight salivary cortisol in the diagnosis of subclinical hypercortisolism in patients with adrenal incidentaloma","volume":"160","author":"Masserini","year":"2009","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.beem.2012.02.001_bib17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1365-2265.1995.tb01852.x","article-title":"Reduced serum levels of dehydroepiandrosterone sulphate in adrenal incidentaloma: a marker of adrenocortical tumor","volume":"42","author":"Flecchia","year":"1995","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1016\/j.beem.2012.02.001_bib18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.1365-2265.1997.d01-1751.x","article-title":"Incidentally discovered adrenal mass (incidentaloma): investigation and management of 208 patients","volume":"46","author":"Kasperlik-Zeluska","year":"1997","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1016\/j.beem.2012.02.001_bib19","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1055\/s-2001-16234","article-title":"Autonomy of cortisol secretion in clinically silent adrenal incidentaloma","volume":"33","author":"Tanabe","year":"2001","journal-title":"Hormone and Metabolic Research"},{"key":"10.1016\/j.beem.2012.02.001_bib20","doi-asserted-by":"crossref","DOI":"10.1507\/endocrj.52.463","article-title":"Discrepancies in results of low- and high-dose dexamethasone suppression tests for diagnosing preclinical Cushing\u2019s syndrome","volume":"52","author":"Katabami","year":"2005","journal-title":"Endocrine Journal"},{"key":"10.1016\/j.beem.2012.02.001_bib21","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1210\/jc.2009-2387","article-title":"Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism","volume":"95","author":"Chiodini","year":"2010","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2012.02.001_bib22","first-page":"440","article-title":"Diagnosis and management of Cushing\u2019s syndrome: results of an Italian multicentre study","volume":"84","author":"Invitti","year":"1999","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2012.02.001_bib23","doi-asserted-by":"crossref","first-page":"424","DOI":"10.7326\/0003-4819-138-5-200303040-00013","article-title":"Management of the clinically inapparent adrenal mass (incidentaloma)","volume":"138","author":"Grumbach","year":"2003","journal-title":"Annals of Internal Medicine"},{"issue":"Suppl. 1","key":"10.1016\/j.beem.2012.02.001_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP.15.S1.1","article-title":"American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas","volume":"15","author":"Zeiger","year":"2009","journal-title":"Endocrine Practice"},{"key":"10.1016\/j.beem.2012.02.001_bib25","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ando.2008.09.003","article-title":"Exploration and management of adrenal incidentalomas. French Society of Endocrinologo consensus","volume":"69","author":"Tabarin","year":"2008","journal-title":"Annales D\u2019Endocrinologie"},{"key":"10.1016\/j.beem.2012.02.001_bib26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2265.2010.03794.x","article-title":"Subclinical hypercortisolism: correlation between biochemical diagnostic criteria and clinical aspects","volume":"73","author":"Morelli","year":"2010","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1016\/j.beem.2012.02.001_bib27","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing\u2019s syndrome: an Endocrine Society Clinical practice guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2012.02.001_bib28","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1530\/EJE-10-1147","article-title":"AME position statement on adrenal incidentaloma","volume":"164","author":"Terzolo","year":"2011","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.beem.2012.02.001_bib29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0889-8529(05)70122-5","article-title":"Management approach to adrenal incidentalomas: a view from Rochester, Minnesota","volume":"29","author":"Young","year":"2000","journal-title":"Endocrinology and Metabolism Clinics of North America"},{"key":"10.1016\/j.beem.2012.02.001_bib30","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0889-8529(18)30082-3","article-title":"Epidemiology of Cushing\u2019s syndrome and subclinical disease","volume":"23","author":"Ross","year":"1994","journal-title":"Endocrinology and Metabolism Clinics of North America"},{"key":"10.1016\/j.beem.2012.02.001_bib31","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1210\/jc.2010-2722","article-title":"Diagnosis and treatment of subclinical hypercortisolism","volume":"96","author":"Chiodini","year":"2010","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2012.02.001_bib32","doi-asserted-by":"crossref","first-page":"4869","DOI":"10.1210\/jc.2002-021436","article-title":"Editorial: adrenal incidentaloma modern disease with old complications editorial comment","volume":"87","author":"Angeli","year":"2002","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2012.02.001_bib33","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1210\/jcem.87.3.8277","article-title":"Adrenal incidentaloma: a new cause of the metabolic syndrome?","volume":"87","author":"Terzolo","year":"2002","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2012.02.001_bib34","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1210\/jc.2010-0633","article-title":"Is subclinical Cushing\u2019s syndrome an entity or a statistical fallout from diagnostic testing? Consensus surrounding the diagnosis is required before optimal treatment can be defined","volume":"95","author":"Stewart","year":"2010","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"11","key":"10.1016\/j.beem.2012.02.001_bib35","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1210\/jc.2001-011766","article-title":"Patients with subclinical Cushing\u2019s syndrome due to adrenal adenoma have increased cardiovascular risk","volume":"87","author":"Tauchmanov\u00e0","year":"2002","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2012.02.001_bib36","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11102-005-4024-6","article-title":"Subclinical Cushing\u2019 syndrome","volume":"7","author":"Terzolo","year":"2004","journal-title":"Pituitary"},{"issue":"10","key":"10.1016\/j.beem.2012.02.001_bib37","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1007\/s00268-009-0178-0","article-title":"Cardiovascular risk in patients with nonfunctional adrenal incidentaloma: myth or reality?","volume":"33","author":"Erbil","year":"2009","journal-title":"World Journal of Surgery"},{"key":"10.1016\/j.beem.2012.02.001_bib38","first-page":"637","article-title":"A survey on adrenal incidentaloma in Italy","volume":"85","author":"Mantero","year":"2000","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2012.02.001_bib39","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ecl.2005.01.010","article-title":"The metabolic and cardiovascular risk in Cushing\u2019s syndrome","volume":"34","author":"Pivonello","year":"2005","journal-title":"Endocrinology and Metabolism Clinics of North America"},{"key":"10.1016\/j.beem.2012.02.001_bib40","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1210\/jc.2002-021558","article-title":"Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing\u2019s disease during active disease and 1 year after disease remission","volume":"88","author":"Faggiano","year":"2003","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2012.02.001_bib41","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/07435809609043773","article-title":"Adrenal incidentalomas: a manifestation of the metabolic syndrome?","volume":"22","author":"Reincke","year":"1996","journal-title":"Endocrine Research"},{"key":"10.1016\/j.beem.2012.02.001_bib42","first-page":"520","article-title":"Risk factors and long-term follow-up of adrenal incidentalomas","volume":"84","author":"Barzon","year":"1999","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2012.02.001_bib43","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s002689910095","article-title":"Natural course of adrenal incidentalomas: seven-year follow-up study","volume":"24","author":"Siren","year":"2000","journal-title":"World Journal of Surgery"},{"key":"10.1016\/j.beem.2012.02.001_bib44","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1046\/j.1365-2265.2003.01676.x","article-title":"Does subclinical hypercortisolism adversely affect the bone mineral density of patients with adrenal incidentalomas?","volume":"58","author":"Hadjidakis","year":"2003","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1016\/j.beem.2012.02.001_bib45","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/jbmr.398","article-title":"Risk of new vertebral fractures in patients with adrenal incidentaloma with and without subclinical hypercortisolism: a multicenter longitudinal study","volume":"26","author":"Morelli","year":"2011","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.beem.2012.02.001_bib46","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/BF03346473","article-title":"Weekly clodronate treatment prevents bone loss and vertebral fractures in women with subclinical Cushing\u2019s syndrome","volume":"32","author":"Tauchmanova","year":"2009","journal-title":"Journal of Endocrinological Investigation"},{"key":"10.1016\/j.beem.2012.02.001_bib47","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1530\/eje.0.1470489","article-title":"Long-term follow-up study of patients with adrenal incidentalomas","volume":"147","author":"Lib\u00e8","year":"2002","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.beem.2012.02.001_bib48","first-page":"55","article-title":"Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates","volume":"83","author":"Barzon","year":"1988","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2012.02.001_bib49","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/SLA.0b013e31819a47d2","article-title":"Surgical versus conservative management for sub-clinical Cushing syndrome in adrenal incidentalomas: a prospective randomized study","volume":"249","author":"Toniato","year":"2009","journal-title":"Annals of Surgery"},{"key":"10.1016\/j.beem.2012.02.001_bib50","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1530\/EJE-09-0775","article-title":"Post surgical hypocortisolism after removal of an adrenal incidentaloma: is it predictable by an accurate endocrinological work-up before surgery?","volume":"162","author":"Eller-Vainicher","year":"2010","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.beem.2012.02.001_bib51","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1530\/eje.0.1320422","article-title":"Abnormalities of endocrine function in patients with clinically silent adrenal masses","volume":"132","author":"Ambrosi","year":"1995","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.beem.2012.02.001_bib52","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.1365-2265.1996.720541.x","article-title":"131I-6-Beta-iodomethylnorcholesterol scintigraphy: an assessment of its role in the investigation of adrenocortical incidentalomas","volume":"44","author":"Bardet","year":"1996","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1016\/j.beem.2012.02.001_bib53","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0026-0495(97)90176-1","article-title":"Evaluation of hormonal function in a series incidentally discovered adrenal masses","volume":"46","author":"Bondanelli","year":"1997","journal-title":"Metabolism"},{"key":"10.1016\/j.beem.2012.02.001_bib54","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1365-2265.1998.00509.x","article-title":"Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas","volume":"49","author":"Tsagarakis","year":"1998","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1016\/j.beem.2012.02.001_bib55","first-page":"1440","article-title":"Subclinical Cushing\u2019s syndrome in patients with adrenal incidentaloma: clinical and biochemical features","volume":"85","author":"Rossi","year":"2000","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2012.02.001_bib56","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1067\/msy.2000.109965","article-title":"Management of incidentally discovered adrenal masses and risk of malignancy","volume":"128","author":"Favia","year":"2000","journal-title":"Surgery"},{"key":"10.1016\/j.beem.2012.02.001_bib57","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1046\/j.1365-2265.2001.01274.x","article-title":"The improvement of insulin resistance in patients with adrenal incidentalomas by surgical resection","volume":"54","author":"Midorikawa","year":"2001","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1016\/j.beem.2012.02.001_bib58","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/BF03343941","article-title":"The natural history of incidentally discovered adrenocortical adenomas: a retrospective evaluation","volume":"24","author":"Grossrubatscher","year":"2001","journal-title":"Journal of Endocrinological Investigation"},{"key":"10.1016\/j.beem.2012.02.001_bib59","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1507\/endocrj.50.399","article-title":"Prevalence of subclinical Cushing\u2019s syndrome in 70 patients with adrenal incidentalomas: clinical, biochemical and surgical outcomes","volume":"50","author":"Emral","year":"2003","journal-title":"Endocrine Journal"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X12000188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X12000188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:46:15Z","timestamp":1761497175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X12000188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S1521690X12000188"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2012.02.001","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subclinical Cushing\u2019s syndrome","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2012.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}